ALIGNMENT HEALTHCARE, INC.
ALIGNMENT HEALTHCARE, INC. (ALHC) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
• Alignment Healthcare runs Medicare Advantage plans the way a clinical operation runs, taking full responsibility for a member's health outcomes and total cost of care in exchange for a fixed monthly payment per member, and the model is finally scaling: first-quarter 2026 revenue reached $1.2 billion, up 33% year over year, on health-plan membership of roughly 284,800. • The price is the whole risk here: at about 21.8 times book value, the shares cost more per dollar of equity than almost any h
Is ALHC overvalued? See what's priced in →
281 institutional managers reported holding ALHC in 13F filings for the quarter ended 2026-03-31. Together they hold about 95% of the company; the top 10 hold 51%. 66 opened new positions that quarter. Held by Vanguard Group, Wellington Management, FMR (Fidelity), among others. On the short side, 25.4M shares were sold short as of the 2026-06-15 count, about 12% of shares outstanding (3.1 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
Open-market insider buys at ALHC over the trailing three years: 2024: 1 buy totaling $496k; 2026: 1 buy totaling $198k. 20 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ALHC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-04 | +7.5% | +13.5% |
| 2023-11-03 | -9.6% | +32.1% |
| 2024-02-28 | -8.9% | -7.8% |
| 2024-05-03 | +27.0% | +20.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ALHC's latest 8-K filings: 2026-06-09 (items 5.07); 2026-05-12 (items 5.03, 7.01); 2026-04-30 (items 2.02, 9.01); 2026-03-04 (items 1.01, 9.01); 2026-02-26 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.